Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
Trial Parameters
Brief Summary
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
Eligibility Criteria
Inclusion Criteria: \- Women ages 25-49 years Exclusion Criteria: * Pregnant women * Women ≤6 weeks postpartum * Women already confirmed to have cervical cancer